HIGH TIDE INC (HITI)
CA42981E4013 - Common Stock
Taking everything into account, HITI scores 4 out of 10 in our fundamental rating. HITI was compared to 196 industry peers in the Pharmaceuticals industry. While HITI seems to be doing ok healthwise, there are quite some concerns on its profitability. HITI is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
In the past year HITI was profitable.
In the past year HITI had a positive cash flow from operations.
In the past 5 years HITI always reported negative net income.
In multiple years HITI reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a decent Return On Assets value of -14.51%, HITI is doing good in the industry, outperforming 66.67% of the companies in the same industry.
With a decent Return On Equity value of -24.34%, HITI is doing good in the industry, outperforming 69.23% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 3.73%, HITI belongs to the top of the industry, outperforming 81.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.51% | ||
| ROE | -24.34% | ||
| ROIC | 3.73% |
ROA(3y)-19.16%
ROA(5y)-26.31%
ROE(3y)-33.35%
ROE(5y)-88.22%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HITI has a better Operating Margin (1.76%) than 77.44% of its industry peers.
Looking at the Gross Margin, with a value of 27.56%, HITI is in line with its industry, outperforming 53.85% of the companies in the same industry.
In the last couple of years the Gross Margin of HITI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.76% | ||
| PM (TTM) | N/A | ||
| GM | 27.56% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.06%
GM growth 5Y-5.4%
2. Health
2.1 Basic Checks
HITI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for HITI has been increased compared to 1 year ago.
Compared to 5 years ago, HITI has more shares outstanding
The debt/assets ratio for HITI is higher compared to a year ago.
2.2 Solvency
HITI has an Altman-Z score of 2.60. This is not the best score and indicates that HITI is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of HITI (2.60) is better than 71.28% of its industry peers.
The Debt to FCF ratio of HITI is 2.31, which is a good value as it means it would take HITI, 2.31 years of fcf income to pay off all of its debts.
HITI has a Debt to FCF ratio of 2.31. This is amongst the best in the industry. HITI outperforms 93.85% of its industry peers.
A Debt/Equity ratio of 0.33 indicates that HITI is not too dependend on debt financing.
The Debt to Equity ratio of HITI (0.33) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.33 | ||
| Debt/FCF | 2.31 | ||
| Altman-Z | 2.6 |
ROIC/WACC0.42
WACC8.81%
2.3 Liquidity
A Current Ratio of 1.17 indicates that HITI should not have too much problems paying its short term obligations.
With a Current ratio value of 1.17, HITI is not doing good in the industry: 81.54% of the companies in the same industry are doing better.
A Quick Ratio of 0.72 indicates that HITI may have some problems paying its short term obligations.
With a Quick ratio value of 0.72, HITI is not doing good in the industry: 86.67% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.17 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 135.64% over the past year.
The Revenue has grown by 36.66% in the past year. This is a very strong growth!
The Revenue has been growing by 123.48% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)135.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.97%
Revenue 1Y (TTM)36.66%
Revenue growth 3Y80.26%
Revenue growth 5Y123.48%
Sales Q2Q%4.93%
3.2 Future
HITI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 69.57% yearly.
Based on estimates for the next years, HITI will show a quite strong growth in Revenue. The Revenue will grow by 14.21% on average per year.
EPS Next Y41.08%
EPS Next 2Y80.62%
EPS Next 3Y80.41%
EPS Next 5Y69.57%
Revenue Next Year5.84%
Revenue Next 2Y9.26%
Revenue Next 3Y12.84%
Revenue Next 5Y14.21%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 53.50, which means the current valuation is very expensive for HITI.
Based on the Price/Earnings ratio, HITI is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 30.79. HITI is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 38.39 indicates a quite expensive valuation of HITI.
Based on the Price/Forward Earnings ratio, HITI is valued a bit cheaper than the industry average as 74.36% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.21. HITI is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 53.5 | ||
| Fwd PE | 38.39 |
4.2 Price Multiples
HITI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. HITI is cheaper than 96.41% of the companies in the same industry.
92.82% of the companies in the same industry are more expensive than HITI, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.99 | ||
| EV/EBITDA | 6.13 |
4.3 Compensation for Growth
HITI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as HITI's earnings are expected to grow with 80.41% in the coming years.
PEG (NY)1.3
PEG (5Y)N/A
EPS Next 2Y80.62%
EPS Next 3Y80.41%
5. Dividend
5.1 Amount
No dividends for HITI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HIGH TIDE INC
NASDAQ:HITI (9/19/2024, 6:16:13 PM)
After market: 2.188 +0.05 (+2.24%)2.14
+0.03 (+1.42%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap172.15M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 53.5 | ||
| Fwd PE | 38.39 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.3
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.51% | ||
| ROE | -24.34% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 1.76% | ||
| PM (TTM) | N/A | ||
| GM | 27.56% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.33 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.17 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)135.64%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y41.08%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)36.66%
Revenue growth 3Y80.26%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y